關於本所
簡史
所長
組織
研究人員
全所研究人員
神經科學
心臟血管與代謝疾病
感染疾病與免疫學
癌症
研究資源
行政單位
核心設施
計畫補助
活動訊息
消息
演講
研討會
徵才育才
工作機會
教育學程
所內連結
WebMail
內部網頁
本所論文集
常用連結
儀器線上預約系統
EN
羅傅倫博士
特聘研究員
Division Chief
02-2789-9152 (Lab) (Room No: N233)
02-2652-3079 (Office)
02-2782-9142 (Fax)
Specialty:
Antibody Engineering
Directed Molecular Evolution
Prodrugs
Anti-PEG antibodies
Nanomedicines
Education and Positions:
Ph.D. University of California, Berkeley
Dr. Roffler, Steve R. 's
Research Highlights
Dr. Roffler, Steve R. 's Lab
Dr. Roffler, Steve R. 's Research Highlights
Bispecific Antibody (HER2 × mPEG) Enhances Anti-Cancer Effects by Precise Targeting and Accumulation of mPEGylated Liposomes
Acta Biomaterialia, May 15, 2020
Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
ACS Nano, Mar 06, 2020
Both IgM and IgG Antibodies Against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice
Pharmaceutics, Dec 21, 2019
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer
Biomaterials Science, Jun 28, 2019
Transient AID expression for in situ mutagenesis with improved cellular fitness
Scientific Reports, Jun 20, 2018
«
1
2
3
4
5
»